Company Comparison
Evelo Biosciences vs BioAnalytics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Evelo Biosciences | BioAnalytics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge, Massachusetts | Boston |
| Founded | 2014 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series B |
| Total Funding | $260M | $55M |
| Valuation | — | — |
What They Build
Evelo Biosciences
Clinical-stage biotechnology company developing oral therapies that modulate the gut microbiome to treat inflammatory diseases.
BioAnalytics
Boston-based biotech company developing analytics and data solutions for the life sciences industry.
Key Investors
Evelo Biosciences
BioAnalytics
No investors listed.
Sector Overlap
Both Evelo Biosciences and BioAnalytics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
14-day free trial. No credit card required.